Search results for "Infectious diseases"


 
Results 91 - 100 of about 297 for "Infectious diseases".
Sort by: Relevance | Newest | Oldest

New data on delta variant of COVID-19 and vaccines

Recent research found that the risk of myocarditis and both arterial and venous clots is higher with COVID-19 infection than with vaccine administration. Other studies show that the COVID-19 delta variant has been associated with reduced mRNA vaccine effectiveness (from 91% to 66%) and an overall increased severity of illness.
https://immattersacp.org/weekly/archives/2021/08/31/1.htm
31 Aug 2021

Progress and limitations on vaccines, strokes and readmissions in COVID-19

A report warned that a few health care workers developed COVID-19 shortly after vaccination, and studies showed that strokes were rare in COVID-19 patients but readmissions could not be predicted easily.
https://immattersacp.org/weekly/archives/2021/02/09/1.htm
9 Feb 2021

ACP, Annals of Internal Medicine host ‘Monkeypox: Challenging Clinical Questions’

The virtual forum featured a panel of physicians providing answers to commonly asked questions about the human monkeypox virus and is available for replay online.
https://immattersacp.org/weekly/archives/2022/10/18/5.htm
18 Oct 2022

Risk of re-infection, benefits of anticoagulation, cause of sex differences among COVID-19 research

Researchers published evidence of re-infection with SARS-CoV-2, anticoagulation was associated with halved inpatient mortality, recommendations were made on pulmonary embolism in COVID-19, and a study attributed differences in men's and women's outcomes to T cells.
https://immattersacp.org/weekly/archives/2020/09/01/2.htm
1 Sep 2020

CDC issues interim guidance on evaluation, treatment of suspected vaping injuries

The evaluation of patients with suspected e-cigarette, or vaping, product use-associated lung injury (EVALI) should include pulse oximetry, chest X-ray, and, in some cases, chest CT, the CDC advised.
https://immattersacp.org/weekly/archives/2019/10/22/2.htm
22 Oct 2019

New research adds to data on symptoms after COVID-19, vaccines' effects

Several COVID-19 studies looked at persistent symptoms, while new vaccine research found limited antibody responses in some patients and advised on tests for clotting complications. Other studies quantified the target population for tocilizumab treatment and gender differences in infections.
https://immattersacp.org/weekly/archives/2021/05/25/1.htm
25 May 2021

Antivirals plus antibiotics may lower risk of hospitalization in some patients with influenza

Although combination antiviral and antibiotic therapy was associated with a significant reduction in respiratory hospitalization risk within 30 days compared to an antiviral alone in this study, that does not mean the combination should be widely used, the authors noted.
https://immattersacp.org/weekly/archives/2020/02/04/2.htm
4 Feb 2020

Oral lefamulin noninferior to oral moxifloxacin in treating community-acquired bacterial pneumonia

Approved by the FDA in August, lefamulin is an “important addition to the current antibiotic armamentarium,” although barriers to use will likely include cost and tolerability concerns, an editor's note said.
https://immattersacp.org/weekly/archives/2019/10/01/2.htm
1 Oct 2019

CDC issues interim guidance on measles infection control and prevention in health care

New government guidance covers what is acceptable evidence of immunity to measles and how to respond if health care personnel are exposed to the disease.
https://immattersacp.org/weekly/archives/2019/07/30/4.htm
30 Jul 2019

COVID-19 research covers taste and smell alterations, incidence in nursing homes and shelters, resource allocation policies

Other topics of note this week include guidance from the Infectious Diseases Society of America (IDSA) on personal protective equipment, plus information from the FDA and IDSA on serum antibody tests.
https://immattersacp.org/weekly/archives/2020/04/28/1.htm
28 Apr 2020

Result Page: Prev   5   6   7   8   9   10   11   12   13   14   Next